Results 21 to 30 of about 129,223 (217)

Quality of care and adherence to antiretroviral drugs in specialized HIV services in Pernambuco/Brazil, 2017-2018

open access: yesSaúde em Debate, 2021
The aim of this study was to evaluate health care quality and medication adherence in people living with human immunodeficiency virus in specialized care services.
Danielle Chianca de Andrade Moraes   +3 more
doaj   +2 more sources

Peripheral Anti-nociceptive and Anti-inflammatory Effect of OleanoliAcid in a Rat Model of Osteoarthritis [PDF]

open access: yes, 2021
Background: Oleanolic acid (OA) is a naturally occurring pentacyclic triterpenoid with multifarious actions. The anti-inflammatory effect it exerts when taken orally is the most important; however, the underpinning mechanisms of such effects have not yet
Fouani, Malak   +3 more
core   +1 more source

Design, Synthesis and Biological Evaluation of a Novel Series of Thiadiazole-Based Anticancer Agents as Potent Angiogenesis Inhibitors

open access: yes, 2021
Background: Thiadiazole has attracted a great deal of interest as a versatile heterocycle for the discovery and development of potent anticancer agents. Thiadiazole derivatives exert potent antitumor activity against a variety of human cancer cell lines ...
Turan, Gulhan   +10 more
core   +1 more source

EXTH-34. ANTI-RETROVIRAL REPURPOSING FOR TREATMENT OF GLIOBLASTOMA

open access: yes, 2022
Glioblastoma (GBM) is a WHO grade IV glioma whose heterogeneous nature and stem-like features contribute to resistance to conventional chemotherapeutics.
Valdez, Mynor Mendez   +4 more
core   +1 more source

Antiretroviral therapy improves neurocognitive impairment in people living with HIV? A meta-analysis

open access: yesInternational Journal of Nursing Sciences, 2020
Objectives: Although effective antiretroviral therapy (ART) has been used for more than two decades, HIV-associated neurocognitive disorder remains prevalent. Thus, whether ART can improve neurocognitive impairment is controversial.
Chang Gao   +5 more
doaj   +1 more source

A longitudinal evaluation of the impact of a polylactic acid injection therapy on health related quality of life amongst HIV patients treated with anti-retroviral agents under real conditions of use [PDF]

open access: yesBMC Infectious Diseases, 2013
Many HIV patients receiving antiretroviral treatment develop lipodystrophy. NEW-FILL® is a polylactic acid injected to treat facial lipoatrophy. The objectives of this study were to describe (1) change in quality of life (QoL) of HIV patients treated with NEW-FILL® in the management of facial lipoatrophy; (2) efficacy of NEW-FILL® using facial ...
Duracinsky, Martin   +5 more
openaire   +2 more sources

Study of Basic Coagulation Parameters among HIV Patients in Correlation to CD4 Counts and Art Status [PDF]

open access: yesJournal of Clinical and Diagnostic Research, 2016
Introduction: HIV infection is known to cause coagulation abnormalities by various mechanism, especially during its late course. Aim: The objective of this study is to analyse platelet count, prothrombin time and activated partial thromboplastin time
R Thulasi Raman   +5 more
doaj   +1 more source

Dependence of АRT efficiency from the infection route in HIV infected patients

open access: yesZaporožskij Medicinskij Žurnal, 2017
The most rapid growth rate of the epidemic process of HIV in Ukraine is observed among injection drug users (IDUs). Substitution maintenance therapy (SMT) with methadone and buprenorphine significantly increases the patients’ maintenance in treatment due
D. H. Zhyvytsia, V. H. Kazeka
doaj   +1 more source

Anti-Human Immunodeficiency Virus (HIV) Agents

open access: yes, 2005
This article gives a brief review of anti-retroviral agents with activity against the Human Immunodeficiency Virus (HIV) the causative agen of Acquired Immunodeficiency Syndrome (AIDS).
Okolie, MN   +5 more
core   +1 more source

Structures, targets and recent approaches in anti-leishmanial drug discovery and development. [PDF]

open access: yes, 2011
Recent years have seen a significant improvement in available treatment options for leishmaniasis. Two new drugs, miltefosine and paromomycin, have been registered for the treatment of visceral leishmaniasis (VL) in India since 2002.
Karin Seifert, Seifert, Karin
core   +1 more source

Home - About - Disclaimer - Privacy